The company aims to target cancer with new drugs that take advantage of protein degradation
The drug did not significantly improve overall survival or progression free survival in the first-line setting
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
Updated Date: Thu, 04 Jun 2020 00:00:00 EDT
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine kblankenship Thu, 06/11/2020 – 14:49
“I don’t believe the virus is under control, and I don’t believe that the system of surveillance we […]